Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02379572 : Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas
PhaseN/A
AgesMin: 18 Years Max: 80 Years
Eligibility
Inclusion Criteria:

1. In MRI suspected primary singular untreated GBM

2. Planned total resection of the tumor according to the surgeon

3. Patient =18 years, =80 years

4. Preoperative KPS = 60%, American Society of Anesthesiologists (ASA) score 1 and 2

5. Patients' informed consent

Exclusion Criteria:

1. Tumors of the midline, basal ganglia, cerebellum, brain stem, eloquent areas

2. Multifocal glioblastoma

3. Substantial (>50%), non-contrast enhancing tumor areas suggesting low-grade glioma
with malignant transformation

4. Contraindications to MRI

5. Inability to give consent because of language barrier or dysphasia

6. Histological diagnosis other than Glioblastoma multiforme WHO °IV

7. Increased risk of thrombosis (e.g. Factor V Leiden)

8. Pregnancy or breast feeding

9. Hypersensibility for 5-ALA oder porphyrins

10. Acute or chronic Porphyria

11. Renal insufficiency

12. Hepatic insufficiency

13. High likelihood of inability to receive adjuvant therapy
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02379572      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740